In summary, the available evidence in CKD populations suggests that, similarly to the general population, those with high Lp(a) levels are at increased risk of cardiovascular disease, although it remains unclear whether the increased risk is apo(a) isoform size dependent. The gene discussed is LPA; the disease is chronic kidney disease.